1. Dos and Don’ts for High-Risk Elderly Patients With AF

2. Why Anticoagulate?

3. Anticoagulate Even in High-Risk Patients ?

4. Efficacy and Safety of NOACs vs Warfarin in NVAF by Age

5. Efficacy and Safety of Edoxaban vs Warfarin by Age in ENGAGE AF-TIMI 48

6. Efficacy and Safety of NOACs vs Warfarin in the ≥75 Age Group

7. Case Study

8. Case Study (cont)

9. Case Study: Delayed Cardioversion

10. Case Study: GI Bleed

11. Case Study: NOAC Switch

12. Case Study: Planned Cardioversion

13. Recommendations for Elderly Patients With AF

14. Prespecified CrCl Subgroups in ENGAGE AF-TIMI 48

15. Bleeding With Edoxaban and Warfarin by Concomitant Antiplatelet Use

16. Factors to Consider in High-Risk Patients With AF

17. Summary

18. Abbreviations

19. Abbreviations (cont)

20. Abbreviations (cont)